Through its clinical trials network, extending across various centres nationwide, CANMAT provides the pharmaceutical industry with a ready resource for clinical research projects - in terms of both expertise and infrastructure. The breadth of research expertise within CANMAT opens up numerous opportunities for the development of integrated preclinical and clinical programs.

The establishment of a working, ethical partnership with industry is clearly vital to the lifeblood of clinical research in this country, and this will be a strong thrust of CANMAT. Currently, CANMAT is forging such relationships with industry, in the research and development of new treatments for mood and anxiety disorders.

TREATMENT OF DEPRESSIVE DISORDERS

CLINICAL TRIALS

Interview: Clinical Trials – Text

Clinical Trials
Robin Reesal, MD, FRCPC
Western Canada Behaviour Research Centre
Calgary, AB